Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency.

Al-Zahrani D, Raddadi A, Massaad M, Keles S, Jabara HH, Chatila TA, Geha R. Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency. Clin Immunol. 2014 Jul; 153(1):104-108.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.